<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04765501</url>
  </required_header>
  <id_info>
    <org_study_id>E-77082166-604.01.02-27514</org_study_id>
    <nct_id>NCT04765501</nct_id>
  </id_info>
  <brief_title>Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Headache Impact Questionnaire</brief_title>
  <official_title>Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Headache Impact Questionnaire</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate cultural adaptation, reliability and validity of&#xD;
      the Turkish version of the Headache Impact Questionnaire (HIQ).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The episodic nature of migraine attacks presents a number of difficulties in characterizing&#xD;
      disease severity. There are differences in the severity, frequency and intensity of attacks&#xD;
      and the general effect of the disease in individuals. Information about any particular attack&#xD;
      is not sufficient to characterize the overall severity of the disease. Accordingly, the&#xD;
      Headache Impact Questionnaire (HIQ) was developed to evaluate the headache experience over a&#xD;
      period of time instead of any headache. Developed to measure the impact and quality of life&#xD;
      of individuals suffering from headache, hÄ±q evaluates the frequency and duration of headache,&#xD;
      the degree of pain severity, daily life activities, disruptions in work or school life, the&#xD;
      influence of the individual's leisure activities and other symptoms that may occur. HIQ&#xD;
      consists of 16 items and the higher the score shows the seriousness of the impact. The study&#xD;
      is planned with 80 individuals with complaint of headache. After questioning the&#xD;
      sociodemographic characteristics of the individuals, the patients will be asked to fill in&#xD;
      HIQ, Migraine Disability Assessment Questionnaire, Headache Impact Test-6 and Short&#xD;
      Form-36.Test-retest will be re-applied to those of the same individuals who can be reached&#xD;
      after 1 week. The results will be analyzed using the SPSS version 22.0 computer package&#xD;
      program.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Headache Impact Questionnaire (HIQ)</measure>
    <time_frame>15 minutes</time_frame>
    <description>Headache Impact Questionnaire is designed to measure the quality of life related to the disability</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Headache</condition>
  <condition>Headache Disorders</condition>
  <condition>Headache, Migraine</condition>
  <condition>Headache, Tension</condition>
  <condition>Headaches Chronic</condition>
  <condition>Headaches Muscular</condition>
  <arm_group>
    <arm_group_label>Patients group</arm_group_label>
    <description>Individuals with headache</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey study</intervention_name>
    <description>Headache Impact Questionnaire (HIQ) will be applied.</description>
    <arm_group_label>Patients group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of individuals with any type of headache.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with any type of headache,&#xD;
&#xD;
          -  Have a chronic headache.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having a cognitive and neurological disorders.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Halime ARIKAN, MSc.</last_name>
    <phone>05465765132</phone>
    <email>halimearikan92@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Halime ARIKAN</name>
      <address>
        <city>Ankara</city>
        <state>None Selected</state>
        <zip>06490</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Halime ARIKAN</last_name>
      <email>halimearikan92@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 19, 2021</study_first_submitted>
  <study_first_submitted_qc>February 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>May 1, 2021</last_update_submitted>
  <last_update_submitted_qc>May 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Halime ARIKAN</investigator_full_name>
    <investigator_title>Research Assistant</investigator_title>
  </responsible_party>
  <keyword>Headache</keyword>
  <keyword>Reliability</keyword>
  <keyword>Validity</keyword>
  <keyword>Cross-cultural adaptation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache Disorders</mesh_term>
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Tension-Type Headache</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

